TW200634001A - Novel compounds - Google Patents

Novel compounds

Info

Publication number
TW200634001A
TW200634001A TW094144382A TW94144382A TW200634001A TW 200634001 A TW200634001 A TW 200634001A TW 094144382 A TW094144382 A TW 094144382A TW 94144382 A TW94144382 A TW 94144382A TW 200634001 A TW200634001 A TW 200634001A
Authority
TW
Taiwan
Prior art keywords
novel compounds
diseases
ethyl
substituted
alkyl
Prior art date
Application number
TW094144382A
Other languages
English (en)
Inventor
David Waterson
David Jonas Persson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of TW200634001A publication Critical patent/TW200634001A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
TW094144382A 2004-12-15 2005-12-15 Novel compounds TW200634001A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0427403.1A GB0427403D0 (en) 2004-12-15 2004-12-15 Novel compounds I

Publications (1)

Publication Number Publication Date
TW200634001A true TW200634001A (en) 2006-10-01

Family

ID=34090044

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094144382A TW200634001A (en) 2004-12-15 2005-12-15 Novel compounds

Country Status (30)

Country Link
US (1) US8129412B2 (zh)
EP (1) EP1828166B1 (zh)
JP (1) JP5042849B2 (zh)
KR (1) KR20070090921A (zh)
CN (1) CN101080402B (zh)
AR (1) AR051797A1 (zh)
AU (1) AU2005315459B2 (zh)
BR (1) BRPI0519057A2 (zh)
CA (1) CA2589525A1 (zh)
CY (1) CY1109376T1 (zh)
DE (1) DE602005015617D1 (zh)
DK (1) DK1828166T3 (zh)
ES (1) ES2328836T3 (zh)
GB (1) GB0427403D0 (zh)
HK (1) HK1108435A1 (zh)
HR (1) HRP20090489T1 (zh)
IL (1) IL183590A0 (zh)
MX (1) MX2007006744A (zh)
NO (1) NO20073550L (zh)
NZ (1) NZ555684A (zh)
PL (1) PL1828166T3 (zh)
PT (1) PT1828166E (zh)
RS (1) RS51193B (zh)
RU (1) RU2388758C2 (zh)
SA (1) SA05260406B1 (zh)
SI (1) SI1828166T1 (zh)
TW (1) TW200634001A (zh)
UA (1) UA89067C2 (zh)
WO (1) WO2006064218A1 (zh)
ZA (1) ZA200705068B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0818006B8 (pt) 2007-10-19 2021-05-25 Boehringer Ingelheim Int compostos de piperidino-di-hidrotienopirimidinas substituídas, uso dos mesmos e formulações farmacêuticas
WO2009138777A1 (en) * 2008-05-12 2009-11-19 Astrazeneca Ab Process for the preparation of alkoxy-phenoxy-pi peridine
US7759512B2 (en) 2008-07-21 2010-07-20 3M Innovative Properties Company Aqueous methods for making fluorinated sulfonate esters
CN102234287B (zh) 2010-04-26 2015-08-05 上海阳帆医药科技有限公司 硝基咪唑类化合物、其制备方法和用途
US9255074B2 (en) 2010-07-16 2016-02-09 Abbvie Inc. Process for preparing antiviral compounds
MY167881A (en) 2010-07-16 2018-09-26 Abbvie Bahamas Ltd Process for preparing antiviral compounds
MX338725B (es) 2010-07-16 2016-04-28 Abbvie Bahamas Ltd Ligando de fosfina para reacciones cataliticas.
US8975443B2 (en) 2010-07-16 2015-03-10 Abbvie Inc. Phosphine ligands for catalytic reactions
HUP1300139A2 (en) 2013-03-06 2014-09-29 Richter Gedeon Nyrt Phenoxypiperidine h3 antagonists
US20160364553A1 (en) * 2015-06-09 2016-12-15 Intel Corporation System, Apparatus And Method For Providing Protected Content In An Internet Of Things (IOT) Network
GB201610056D0 (en) * 2016-06-09 2016-07-27 Galapagos Nv And Laboratoires Servier Les Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9919776D0 (en) * 1998-08-31 1999-10-27 Zeneca Ltd Compoujnds
JP2003501414A (ja) * 1999-06-04 2003-01-14 アストラゼネカ・アクチエボラーグ メタロプロテイナーゼの阻害剤
WO2001062742A1 (en) * 2000-02-21 2001-08-30 Astrazeneca Ab Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
SE0100902D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0301922D0 (sv) 2003-06-27 2003-06-27 Astrazeneca Ab Novel compounds

Also Published As

Publication number Publication date
CY1109376T1 (el) 2014-07-02
HRP20090489T1 (hr) 2009-10-31
EP1828166B1 (en) 2009-07-22
RU2388758C2 (ru) 2010-05-10
SA05260406B1 (ar) 2009-02-02
JP2008524184A (ja) 2008-07-10
AU2005315459A1 (en) 2006-06-22
HK1108435A1 (en) 2008-05-09
WO2006064218A1 (en) 2006-06-22
US8129412B2 (en) 2012-03-06
DK1828166T3 (da) 2009-10-05
RS51193B (sr) 2010-10-31
RU2007121222A (ru) 2009-01-27
ZA200705068B (en) 2008-10-29
SI1828166T1 (sl) 2009-12-31
BRPI0519057A2 (pt) 2008-12-23
JP5042849B2 (ja) 2012-10-03
CA2589525A1 (en) 2006-06-22
CN101080402B (zh) 2010-12-08
EP1828166A1 (en) 2007-09-05
NO20073550L (no) 2007-09-11
US20080280950A1 (en) 2008-11-13
AU2005315459B2 (en) 2009-01-08
GB0427403D0 (en) 2005-01-19
MX2007006744A (es) 2007-07-09
IL183590A0 (en) 2007-09-20
PL1828166T3 (pl) 2009-12-31
ES2328836T3 (es) 2009-11-18
DE602005015617D1 (de) 2009-09-03
CN101080402A (zh) 2007-11-28
PT1828166E (pt) 2009-09-16
KR20070090921A (ko) 2007-09-06
AR051797A1 (es) 2007-02-07
UA89067C2 (ru) 2009-12-25
NZ555684A (en) 2009-11-27

Similar Documents

Publication Publication Date Title
TW200634001A (en) Novel compounds
TW200745111A (en) New compounds
MXPA04009163A (es) Nuevos compuestos.
TW200621762A (en) Novel compounds
TW200626553A (en) Novel compounds
TW200606164A (en) New compounds
NO20065904L (no) Terapeutiske forbindelser
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
TW200639156A (en) New compounds
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
GB0112348D0 (en) Compounds
NO20070837L (no) Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer.
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
BR0313407A (pt) Novo uso de derivados de benzotiazol
TW200605888A (en) Novel compounds
SE0100569D0 (sv) New compounds
TW200800984A (en) New compounds
SE0302546D0 (sv) New compounds
TW200728291A (en) Amide derivatives
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
TW200626581A (en) Compounds, compositions containing them, preparation thereof and uses thereof
MXPA05010020A (es) Derivados de oxamida.
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders